Malaria transmission intensity likely modifies RTS, S/AS01 efficacy due to a rebound effect in Ghana, Malawi, and Gabon

GJ Bell, V Goel, P Essone, D Dosoo… - The Journal of …, 2022 - academic.oup.com
Abstract Background RTS, S/AS01 is the first malaria vaccine to be approved and
recommended for widespread implementation by the World Health Organization (WHO) …

Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan children

RM Mugo, K Mwai, J Mwacharo, FM Shee, JN Musyoki… - Malaria Journal, 2021 - Springer
Abstract Background RTS, S/AS01, the leading malaria vaccine has been recommended by
the WHO for widespread immunization of children at risk. RTS, S/AS01-induced anti-CSP …

A cutting-edge immunoinformatics approach for design of multi-epitope oral vaccine against dreadful human malaria

M Pritam, G Singh, S Swaroop, AK Singh… - International Journal of …, 2020 - Elsevier
Human malaria is a pathogenic disease mainly caused by Plasmodium falciparum, which
was responsible for about 405,000 deaths globally in the year 2018. To date, several …

Immune responses to malaria pre‐erythrocytic stages: implications for vaccine development

KM Abuga, W Jones‐Warner… - Parasite immunology, 2021 - Wiley Online Library
Radiation‐attenuated sporozoites induce sterilizing immunity and remain the'gold
standard'for malaria vaccine development. Despite practical challenges in translating these …

Defining species-specific and conserved interactions of apical membrane protein 1 during erythrocyte invasion in malaria to inform multi-species vaccines

DR Drew, DW Wilson, GE Weiss, LM Yeoh… - Cellular and Molecular …, 2023 - Springer
Plasmodium falciparum and P. vivax are the major causes of human malaria, and P.
knowlesi is an important additional cause in SE Asia. Binding of apical membrane antigen 1 …

RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria …

C Dobaño, I Ubillos, C Jairoce, B Gyan, M Vidal… - BMC medicine, 2019 - Springer
Background Vaccination and naturally acquired immunity against microbial pathogens may
have complex interactions that influence disease outcomes. To date, only vaccine-specific …

[HTML][HTML] Modelling the roles of antibody titre and avidity in protection from Plasmodium falciparum malaria infection following RTS, S/AS01 vaccination

HA Thompson, AB Hogan, PGT Walker, MT White… - Vaccine, 2020 - Elsevier
Anti-circumsporozoite antibody titres have been established as an essential indicator for
evaluating the immunogenicity and protective capacity of the RTS, S/AS01 malaria vaccine …

Impacts of ecology, parasite antigenic variation, and human genetics on RTS, S/AS01e malaria vaccine efficacy

GJ Bell, ST Agnandji, KP Asante, A Ghansah… - Current Epidemiology …, 2021 - Springer
Abstract Purpose of Review Global malaria elimination has little chance of success without
an effective vaccine. The first malaria vaccine, RTS, S/AS01e, demonstrated moderate …

Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2

BD Wines, L Kurtovic, HM Trist, S Esparon… - Frontiers in …, 2022 - frontiersin.org
Joining a function-enhanced Fc-portion of human IgG to the SARS-CoV-2 entry receptor
ACE2 produces an antiviral decoy with strain transcending virus neutralizing activity. SARS …

Induction, decay, and determinants of functional antibodies following vaccination with the RTS, S malaria vaccine in young children

G Feng, L Kurtovic, PA Agius, EH Aitken, J Sacarlal… - BMC medicine, 2022 - Springer
Background RTS, S is the first malaria vaccine recommended for implementation among
young children at risk. However, vaccine efficacy is modest and short-lived. Antibodies play …